Literature DB >> 32937020

Cytologic features of undifferentiated and dedifferentiated carcinomas of the endometrium.

Amir-Hossein Akbari1, Lu Wang2, Robert A Soslow2, Rajmohan Murali2.   

Abstract

BACKGROUND: Undifferentiated carcinoma (UC) is a rare, aggressive subtype of endometrial carcinoma. Dedifferentiated carcinomas (DCs) are UCs associated with a component of well differentiated endometrioid carcinoma. The authors sought to describe the morphologic features of UCs and DCs in cytologic specimens.
METHODS: Cytologic specimens from 23 women (aged 46-86 years; median age, 59 years) were reviewed, including cervicovaginal specimens (n = 7), peritoneal washings (n = 5), touch preparations of core biopsies from various sites (n = 5), fine-needle biopsies of lymph nodes (n = 3), ascitic fluid (n = 1), pleural fluid (n = 1), and intrauterine fluid (n = 1).
RESULTS: There were 10 UCs (43%) and 13 DCs (57%). Tumor cells were arranged as single cells (9 UCs, 90%; 12 DCs, 92%) and 3-dimensional groups (8 UCs, 80%; 11 DCs, 85%). Most cases showed high nuclear-to-cytoplasmic ratios. Nuclear molding was observed in 3 UCs (30%) and in 5 DCs (38%). Nuclear chromatin was often coarsely granular 6 UCs, 60%; 9 DCs, 69%). Nucleoli were inconspicuous in some cases (6 UCs, 60%; 8 DCs, 62%) but were appreciable in others. Necrosis was observed in 5 UCs (50%) and in 5 DCs (38%). Most cases exhibited clean backgrounds, and a few showed acute inflammation. Comparison of the cytologic features of UCs and DCs did not reveal any statistically significant differences.
CONCLUSIONS: UCs and DCs have a spectrum of cytomorphologic appearances that are not pathognomonic, but the presence of some of these (relatively uniform population of predominantly singly dispersed cells with high nuclear-to-cytoplasmic ratios and variably conspicuous nucleoli) should prompt consideration of UC and DC in the differential diagnosis.
© 2020 American Cancer Society.

Entities:  

Keywords:  cytology; dedifferentiated carcinoma; endometrium; undifferentiated carcinoma; uterus

Mesh:

Year:  2020        PMID: 32937020      PMCID: PMC7854522          DOI: 10.1002/cncy.22351

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  44 in total

1.  High grade endometrial stromal sarcoma on thinprep.

Authors:  Paula S Ginter; Edyta C Pirog; Rana S Hoda
Journal:  Diagn Cytopathol       Date:  2015-07-14       Impact factor: 1.582

2.  Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

Authors:  Elvio G Silva; Michael T Deavers; Diane C Bodurka; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2006-01       Impact factor: 2.762

3.  Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma.

Authors:  Varsha I Shah; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

4.  Clinicopathologic and Immunohistochemical Characterization of Dedifferentiated Endometrioid Adenocarcinoma.

Authors:  Zaibo Li; Chengquan Zhao
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-09

5.  SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma.

Authors:  Colin J R Stewart; Maxine L Crook
Journal:  Pathology       Date:  2015-08       Impact factor: 5.306

6.  Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.

Authors:  Mackenzie Coatham; Xiaodong Li; Anthony N Karnezis; Lien N Hoang; Basile Tessier-Cloutier; Bo Meng; Robert A Soslow; C Blake Gilks; David G Huntsman; Colin J R Stewart; Lynne M Postovit; Martin Köbel; Cheng-Han Lee
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

7.  Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.

Authors:  Anthony N Karnezis; Lien N Hoang; Mackenzie Coatham; Sarah Ravn; Noorah Almadani; Basile Tessier-Cloutier; Julie Irving; Bo Meng; Xiaodong Li; Christine Chow; Jessica McAlpine; Kuan-Ting Kuo; Tsui-Lien Mao; Bojana Djordjevic; Robert A Soslow; David G Huntsman; C Blake Gilks; Martin Köbel; Cheng-Han Lee
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

8.  Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.

Authors:  Preetha Ramalingam; Ramya P Masand; Elizabeth D Euscher; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2016-09       Impact factor: 2.762

Review 9.  Undifferentiated carcinoma of the endometrium: a review.

Authors:  Elvio G Silva; Michael T Deavers; Anais Malpica
Journal:  Pathology       Date:  2007-02       Impact factor: 5.306

10.  Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma.

Authors:  Colin J R Stewart; Maxine L Crook
Journal:  Hum Pathol       Date:  2015-06-26       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.